India Is One Step Ahead : Covishield, Covaxin Granted Regular Market Approval For Use In Adult Population
he Drugs Controller General of India (DCGI), India’s drug regulator, granted regular market approval for the COVID-19 vaccines Covishield and Covaxin for use in the adult population subject to certain conditions, on Thursday, official sources informed news agency PTI. The regular market approval was granted under the New Drugs and Clinical Trials Rules, 2019.
.
Read more at: https://news.abplive.com/news/india/covishield-covaxin-granted-regular-market-approval-for-use-in-adult-population-1509173
.
Visit www.werindia.com OR Hindi.werindia.com to read news from 500+ news sources... आपका अपना डिजिटल अख़बार |
- 28 Jan 2022
- WerIndia